» Articles » PMID: 28798047

MTOR Regulates Metabolic Adaptation of APCs in the Lung and Controls the Outcome of Allergic Inflammation

Abstract

Antigen-presenting cells (APCs) occupy diverse anatomical tissues, but their tissue-restricted homeostasis remains poorly understood. Here, working with mouse models of inflammation, we found that mechanistic target of rapamycin (mTOR)-dependent metabolic adaptation was required at discrete locations. mTOR was dispensable for dendritic cell (DC) homeostasis in secondary lymphoid tissues but necessary to regulate cellular metabolism and accumulation of CD103 DCs and alveolar macrophages in lung. Moreover, while numbers of mTOR-deficient lung CD11b DCs were not changed, they were metabolically reprogrammed to skew allergic inflammation from eosinophilic T helper cell 2 (T2) to neutrophilic T17 polarity. The mechanism for this change was independent of translational control but dependent on inflammatory DCs, which produced interleukin-23 and increased fatty acid oxidation. mTOR therefore mediates metabolic adaptation of APCs in distinct tissues, influencing the immunological character of allergic inflammation.

Citing Articles

Dendritic cell immunometabolism - a potential therapeutic target for allergic diseases.

Ouyang C, Huang J, Huang G, Wang Y Int J Med Sci. 2025; 22(2):417-431.

PMID: 39781535 PMC: 11704690. DOI: 10.7150/ijms.105532.


Glutamine is critical for the maintenance of type 1 conventional dendritic cells in normal tissue and the tumor microenvironment.

Lobel G, Han N, Molina Arocho W, Silber M, Shoush J, Noji M Proc Natl Acad Sci U S A. 2024; 121(50):e2412157121.

PMID: 39625974 PMC: 11648871. DOI: 10.1073/pnas.2412157121.


Lipid-Laden Macrophages in Pulmonary Diseases.

Zhu Y, Choi D, Somanath P, Zhang D Cells. 2024; 13(11.

PMID: 38891022 PMC: 11171561. DOI: 10.3390/cells13110889.


Immunometabolism of dendritic cells in health and disease.

Guo C, Chi H Adv Immunol. 2023; 160:83-116.

PMID: 38042587 PMC: 11086980. DOI: 10.1016/bs.ai.2023.10.002.


Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles.

Hartmeier P, Kosanovich J, Velankar K, Ostrowski S, Busch E, Lipp M Acta Biomater. 2023; 170:453-463.

PMID: 37652212 PMC: 10592217. DOI: 10.1016/j.actbio.2023.08.048.


References
1.
Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhlmeier K . The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity. 2008; 29(4):565-77. DOI: 10.1016/j.immuni.2008.08.012. View

2.
Pearce E, Everts B . Dendritic cell metabolism. Nat Rev Immunol. 2014; 15(1):18-29. PMC: 4495583. DOI: 10.1038/nri3771. View

3.
Porstmann T, Santos C, Griffiths B, Cully M, Wu M, Leevers S . SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008; 8(3):224-36. PMC: 2593919. DOI: 10.1016/j.cmet.2008.07.007. View

4.
Cao W, Manicassamy S, Tang H, Kasturi S, Pirani A, Murthy N . Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol. 2008; 9(10):1157-64. PMC: 3732485. DOI: 10.1038/ni.1645. View

5.
Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D . IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity. 2013; 38(5):970-83. PMC: 3666057. DOI: 10.1016/j.immuni.2013.04.011. View